| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 3,334 | 20 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 20 Dec 2023 | 1 | $0 | 4 | Director | 21 Dec 2023, 16:05 |
| AVTX | Avalo Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 16:07 |
| AVTX | Avalo Therapeutics, Inc. | 31 Mar 2023 | 1 | $0 | 4 | Director | 04 Apr 2023, 16:07 |
| AVTX | Avalo Therapeutics, Inc. | 30 Dec 2022 | 1 | $0 | 4 | Director | 03 Jan 2023, 15:13 |
| AVTX | Avalo Therapeutics, Inc. | 30 Sep 2022 | 1 | $0 | 4 | Director | 03 Oct 2022, 16:21 |
| AVTX | Avalo Therapeutics, Inc. | 30 Jun 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 17:34 |
| AVTX | Avalo Therapeutics, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:01 |
| AVTX | Avalo Therapeutics, Inc. | 31 Mar 2022 | 1 | $0 | 4 | Director | 04 Apr 2022, 18:25 |
| AVTX | Avalo Therapeutics, Inc. | 31 Dec 2021 | 1 | $0 | 4 | Director | 04 Jan 2022, 15:26 |
| AVTX | Avalo Therapeutics, Inc. | 30 Sep 2021 | 1 | $0 | 4 | Director | 04 Oct 2021, 16:38 |
| AVTX | Cerecor Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 16:02 |
| AVTX | Cerecor Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 16:39 |